Abstract Title:

Early life exposure to phthalates and the development of childhood asthma among Canadian children.

Abstract Source:

Environ Res. 2021 Mar 7 ;197:110981. Epub 2021 Mar 7. PMID: 33691158

Abstract Author(s):

Garthika Navaranjan, Miriam L Diamond, Shelley A Harris, Liisa M Jantunen, Sarah Bernstein, James A Scott, Tim K Takaro, Ruixue Dai, Diana L Lefebvre, Meghan B Azad, Allan B Becker, Piush J Mandhane, Theo J Moraes, Elinor Simons, Stuart E Turvey, Malcolm R Sears, Padmaja Subbarao, Jeffrey R Brook

Article Affiliation:

Garthika Navaranjan


BACKGROUND: Studies have demonstrated an association between phthalate exposure and childhood asthma, although results have been inconsistent. No epidemiological studies have examined exposure during the first year of life.

OBJECTIVE: To investigate the association between phthalate exposures in the home environment during the first year of life, and subsequent development of childhood asthma and related symptoms.

METHODS: This study used a case-cohort design including 436 randomly selected children and all additional cases of asthma at 5 years (n = 129) and recurrent wheeze between 2 and 5 years (n = 332) within the CHILD Cohort Study, a general population Canadian birth cohort of 3455 children. Phthalate exposure was assessed using house dust samples collected during a standardized home visit when children were 3-4 months of age. All children were assessed by specialist clinicians for asthma and allergy at 1, 3 and 5 years. Logistic regression was used to assess the association between exposure to five phthalates and asthma diagnosis at 5 years, and recurrent wheeze between 2 and 5 years, with further stratification by wheeze subtypes (late onset, persistent, transient) based on thetiming of onset and persistence of wheeze symptoms.

RESULTS: Di(2-ethylhexyl) phthalate (DEHP) had the highest concentration in dust (median = 217 μg/g), followed by benzyl butyl phthalate (BzBP) (20 μg/g). A nearly four-fold increase in risk of developing asthma was associated with the highest concentration quartile of DEHP (OR = 3.92, 95% CI: 1.87-8.24) including a positive dose-response relationship. A two-fold increase in risk of recurrent wheeze was observed across all quartiles compared to the lowest quartile of DEHP concentrations. Compared to other wheeze subtypes, stronger associations for DEHP were observed with the late onset wheezing subtype, while stronger associations for di-iso-butyl phthalate (DiBP) and BzBP were observed with the transient subtype.

DISCUSSION: DEHP exposure at 3-4 months, at concentrations lower than other studies that reported an association, were associated with increased risks of asthma and recurrent wheeze among children at 5 years. These findings suggest the need to assess whether more stringent regulations are required to protect children's health, which can be informed by future work exploring the main sources of DEHP exposure.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.